The Leadership Team at Isotopen Technologien München oversees strategic direction, operational efficiency, and innovation within the biotechnology and radiopharmaceutical sectors. Comprising top executives with expertise in finance, research, production, and medical affairs, the team collaborates to drive growth, enhance product development, and ensure compliance with industry standards, ultimately advancing the company's mission to improve patient outcomes through innovative isotopes and therapies.
Klaus Maleck
Chief Financial Officer
Konstantin Zhernosek...
Chief Scientific Officer & Man...
Mark Harfensteller
Managing Director ITM Medical ...
Philip E Harris
Chief Medical Officer, ITM Onc...
Richard Henkelmann
Managing Director ITM Medical ...
Sebastian Marx
Chief Business Officer, ITM Gr...
Steffen Schuster
Stellvertretender Aufsichtsrat...
View all